Drug Eluting Stents Market By Product Type (Polymer-Based Coatings (Non-Biodegradable Polymer-based, Biodegradable Polymer-Based), Polymer-Free Coatings (Micro Porous Surface, Micro Structured Surface, Slotted Tubular Surface, Nanoporous Surface); By Material Type (Cobalt Chromium (CoCr), Stainless Steel, Others); By Application (Coronary Artery Diseases, Peripheral Artery Diseases); By Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018 – 2026

Report ID :AMI-151 | Category : Medical Devices | Published Date :December, 2018 | Pages : 268 | Format :PDF
Buy Now!

Industry Trends:

Drug Eluting Stents (DES) are implantable devices prominently used for the treatment of blocked arteries and blood vessels. It is an interventional method that delivers the drug by a controlled release through a biostable polymer.  Components of drug eluting stents comprise a metallic stent platform, a drug delivery agent and polymer coating. Various drugs including Sirolimus, Everolimus, Paclitaxel, Dexamethasone, etc. are administered through these stents. DES products are explicitly developed to address the problem of restenosis, which is the recurrence of abnormal narrowing of an artery or valve after corrective surgery. Drug eluting stents are available in materials such as cobalt-chromium alloy, stainless steel and others. These cylindrically shaped devices are flexible, biocompatible, thromboresistant and are available in the form of laser-cut designs, coils, woven mesh designs, etc.

The number of patients suffering from diabetes and heart diseases has been increasingly consistently. Additionally, unhealthy diets and sedentary lifestyle habits are resulting in increased incidences of atherosclerosis, which is extensively being treated using drug eluting stents. However, their high cost of drug eluting stents in comparison to conventional stents is hampering the growth of Drug Eluting Stents Market. Some of the major risks associated with the use of traditional metallic implants include post-surgery complications such as neoatherosclerosis, impaired vessel homeostasis, and stent fracture. The ongoing technological advancements such as the use of bioresorbable materials as an alternative for the conventional metallic stents is eliminating several issues that arise after these surgeries. These modifications are extensively impacting a broad adoption of drug eluting stents based treatments.

Drug Eluting Stents Market is expected to grow with a CAGR of 7.5% during the forecast period of 2018 to 2026. The study analyzes the market in terms of revenue and sales volume across all the major markets.

 Asia Pacific Drug Eluting Stents Sales (Thousand Units), 2017-2026

Drug Eluting Stents Market

Competitive Landscape

The report provides both, qualitative and quantitative research of the drug eluting stents market, as well as provides worthy insights into the rational scenario and favored development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarter, competitors, product/service type, application and specification, pricing, and gross margin.

The Drug Eluting Stents Market participants include QualiMed, B. Braun Melsungen AG, Arterius Limited (Arterius), Biosensors International Group, Ltd., Cook Medical Inc.(Cook), KYOTO MEDICAL PLANNING Co., Ltd., Elixir Medical Corporation, Biotronik SE & Co. KG, Abbott Laboratories (Abbott), Shanghai MicroPort Medical (MicroPort Scientific Corporation), TERUMO CORPORATION, Alvimedica, Boston Scientific Corporation, OrbusNeich Medical Company Limited (ORBUSNEICH), and Micell Technologies, Inc. amongst others. Abbott Vascular is a leading manufacturer of drug eluting stents, which is headquartered in California, U.S.A. Their everolimus-eluting platinum chromium coronary stent called Xience V is among the popular DES devices in this market. A similar Everolimus-Eluting Stent (EES) product by the name of PROMUS is launched by Boston Scientific, which is a company based in Marlborough, Massachusetts, US. The ongoing commercialization of drug eluting stents with polymer-free coatings and bioresorbable polymer coatings indicates a continuous growth of Drug Eluting Stents Market.

1.    Introduction

1.1.  Market Scope

1.2.  Market Segmentation

1.3.  Methodology

1.4.  Assumptions

2.    Drug Eluting Stents Market Snapshot

3.    Executive Summary: Drug Eluting Stents Market

4.    Qualitative Analysis: Drug Eluting Stents Market

4.1.   Introduction

4.1.1. Product Definition

4.1.2. Industry Development

4.2.   Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3.   Trends in Drug Eluting Stents Market

5.    Global Drug Eluting Stents Market Analysis and Forecasts, 2018 – 2026

5.1.   Overview

5.1.1.   Global Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts

5.2.   Global Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

5.2.1.   Polymer-Based Coatings (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Non-Biodegradable Polymer-Based , Biodegradable Polymer-Based)

5.2.1.1.  Non-Biodegradable Polymer-Based

5.2.1.2.  Biodegradable Polymer-Based

5.2.2.   Polymer-Free Coatings (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Micro Porous Surface , Micro Structured Surface, Slotted Tubular Surface , Nanoporous Surface)

5.2.2.1.  Micro Porous Surface

5.2.2.2.  Micro Structured Surface

5.2.2.3.  Slotted Tubular Surface

5.2.2.4.  Nanoporous Surface

5.3.   Key Segment for Channeling Investments

5.3.1. By Product Type

6.    Global Drug Eluting Stents Market Analysis and Forecasts, 2018 – 2026

6.1.   Overview

6.2.   Global Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

6.2.1.   Cobalt Chromium (CoCr)

6.2.1.1.  Definition

6.2.1.2.  Market Penetration

6.2.1.3.  Market Revenue Expected to Increase by 2026

6.2.1.4.  Compound Annual Growth Rate (CAGR)

6.2.2.   Stainless Steel

6.2.2.1.  Definition

6.2.2.2.  Market Penetration

6.2.2.3.  Market Revenue Expected to Increase by 2026

6.2.2.4.  Compound Annual Growth Rate (CAGR)

6.2.3.   Others

6.2.3.1.  Definition

6.2.3.2.  Market Penetration

6.2.3.3.  Market Revenue Expected to Increase by 2026

6.2.3.4.  Compound Annual Growth Rate (CAGR)

6.3.   Key Segment for Channeling Investments

6.3.1. By Material Type

7.    Global Drug Eluting Stents Market Analysis and Forecasts, 2018 – 2026

7.1.   Overview

7.2.   Global Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

7.2.1.   Coronary Artery Diseases

7.2.1.1.  Definition

7.2.1.2.  Market Penetration

7.2.1.3.  Market Revenue Expected to Increase by 2026

7.2.1.4.  Compound Annual Growth Rate (CAGR)

7.2.2.   Peripheral Artery Diseases

7.2.2.1.  Definition

7.2.2.2.  Market Penetration

7.2.2.3.  Market Revenue Expected to Increase by 2026

7.2.2.4.  Compound Annual Growth Rate (CAGR)

7.3.   Key Segment for Channeling Investments

7.3.1.   By Application

8.    North America Drug Eluting Stents Market Analysis and Forecasts, 2018 – 2026

8.1.   Overview

8.1.1. North America Drug Eluting Stents Market Revenue (US$ Mn)

8.2.   North America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

8.2.1.   Polymer-Based Coatings

8.2.1.1.  Non-Biodegradable Polymer-Based

8.2.1.2.  Biodegradable Polymer-Based

8.2.2.   Polymer-Free Coatings

8.2.2.1.  Micro Porous Surface

8.2.2.2.  Micro Structured Surface

8.2.2.3.  Slotted Tubular Surface

8.2.2.4.  Nanoporous Surface

8.3.   North America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

8.3.1. Cobalt Chromium (CoCr)

8.3.2. Stainless Steel

8.3.3. Others

8.4.   North America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

8.4.1. Coronary Artery Diseases

8.4.2. Peripheral Artery Diseases

8.5.   North America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Country

8.5.1.   U.S.

8.5.1.1.    U.S. Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

8.5.1.1.1.    Polymer-Based Coatings

8.5.1.1.1.1.Non-Biodegradable Polymer-Based

8.5.1.1.1.2.Biodegradable Polymer-Based

8.5.1.1.2.    Polymer-Free Coatings

8.5.1.1.2.1.  Micro Porous Surface

8.5.1.1.2.2.  Micro Structured Surface

8.5.1.1.2.3.  Slotted Tubular Surface

8.5.1.1.2.4.  Nanoporous Surface

8.5.1.2.    U.S. Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

8.5.1.2.1.   Cobalt Chromium (CoCr)

8.5.1.2.2.   Stainless Steel

8.5.1.2.3.   Others

8.5.1.3.    U.S. Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

8.5.1.3.1.   Coronary Artery Diseases

8.5.1.3.2.   Peripheral Artery Diseases

8.5.2.   Rest of North America

8.5.2.1.    Rest of North America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

8.5.2.1.1.    Polymer-Based Coatings

8.5.2.1.1.1.  Non-Biodegradable Polymer-Based

8.5.2.1.1.2.  Biodegradable Polymer-Based

8.5.2.1.2.    Polymer-Free Coatings

8.5.2.1.2.1.  Micro Porous Surface

8.5.2.1.2.2.  Micro Structured Surface

8.5.2.1.2.3.  Slotted Tubular Surface

8.5.2.1.2.4.  Nanoporous Surface

8.5.2.2.    Rest of North America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

8.5.2.2.1.   Cobalt Chromium (CoCr)

8.5.2.2.2.   Stainless Steel

8.5.2.2.3.   Others

8.5.2.3.    Rest of North America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

8.5.2.3.1.   Coronary Artery Diseases

8.5.2.3.2.   Peripheral Artery Diseases

8.6.   Key Segment for Channeling Investments

8.6.1. By Country

8.6.2. By Product Type

8.6.3. By Material Type

8.6.4. By Application

9.    Europe Drug Eluting Stents Market Analysis and Forecasts, 2018 – 2026

9.1.   Overview

9.1.1.   Europe Drug Eluting Stents Market Revenue (US$ Mn)

9.2.   Europe Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

9.2.1.   Polymer-Based Coatings

9.2.1.1.  Non-Biodegradable Polymer-Based

9.2.1.2.  Biodegradable Polymer-Based

9.2.2.   Polymer-Free Coatings

9.2.2.1.  Micro Porous Surface

9.2.2.2.  Micro Structured Surface

9.2.2.3.  Slotted Tubular Surface

9.2.2.4.  Nanoporous Surface

9.3.   Europe Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

9.3.1.   Cobalt Chromium (CoCr)

9.3.2.   Stainless Steel

9.3.3.   Others

9.4.   Europe Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

9.4.1.   Coronary Artery Diseases

9.4.2.   Peripheral Artery Diseases

9.5.   Europe Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Country

9.5.1.   France

9.5.1.1.    France Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

9.5.1.1.1.    Polymer-Based Coatings

9.5.1.1.1.1.  Non-Biodegradable Polymer-Based

9.5.1.1.1.2.  Biodegradable Polymer-Based

9.5.1.1.2.    Polymer-Free Coatings

9.5.1.1.2.1.  Micro Porous Surface

9.5.1.1.2.2.  Micro Structured Surface

9.5.1.1.2.3.  Slotted Tubular Surface

9.5.1.1.2.4.  Nanoporous Surface

9.5.1.2.    France Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

9.5.1.2.1. Cobalt Chromium (CoCr)

9.5.1.2.2. Stainless Steel

9.5.1.2.3. Others

9.5.1.3.    France Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

9.5.1.3.1. Coronary Artery Diseases

9.5.1.3.2. Peripheral Artery Diseases

9.5.2.   The UK

9.5.2.1.    The UK Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

9.5.2.1.1.    Polymer-Based Coatings

9.5.2.1.1.1.  Non-Biodegradable Polymer-Based

9.5.2.1.1.2.  Biodegradable Polymer-Based

9.5.2.1.2.    Polymer-Free Coatings

9.5.2.1.2.1.  Micro Porous Surface

9.5.2.1.2.2.  Micro Structured Surface

9.5.2.1.2.3.  Slotted Tubular Surface

9.5.2.1.2.4.  Nanoporous Surface

9.5.2.2.    The UK Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

9.5.2.2.1. Cobalt Chromium (CoCr)

9.5.2.2.2. Stainless Steel

9.5.2.2.3. Others

9.5.2.3.    The UK Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

9.5.2.3.1. Coronary Artery Diseases

9.5.2.3.2. Peripheral Artery Diseases

9.5.3.   Spain

9.5.3.1.    Spain Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

9.5.3.1.1.    Polymer-Based Coatings

9.5.3.1.1.1.  Non-Biodegradable Polymer-Based

9.5.3.1.1.2.  Biodegradable Polymer-Based

9.5.3.1.2.    Polymer-Free Coatings

9.5.3.1.2.1.  Micro Porous Surface

9.5.3.1.2.2.  Micro Structured Surface

9.5.3.1.2.3.  Slotted Tubular Surface

9.5.3.1.2.4.  Nanoporous Surface

9.5.3.2.    Spain Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

9.5.3.2.1. Cobalt Chromium (CoCr)

9.5.3.2.2. Stainless Steel

9.5.3.2.3. Others

9.5.3.3.    Spain Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

9.5.3.3.1. Coronary Artery Diseases

9.5.3.3.2. Peripheral Artery Diseases

9.5.4.   Germany

9.5.4.1.    Germany Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

9.5.4.1.1.    Polymer-Based Coatings

9.5.4.1.1.1.  Non-Biodegradable Polymer-Based

9.5.4.1.1.2.  Biodegradable Polymer-Based

9.5.4.1.2.    Polymer-Free Coatings

9.5.4.1.2.1.  Micro Porous Surface

9.5.4.1.2.2.  Micro Structured Surface

9.5.4.1.2.3.  Slotted Tubular Surface

9.5.4.1.2.4.  Nanoporous Surface

9.5.4.2.    Germany Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

9.5.4.2.1. Cobalt Chromium (CoCr)

9.5.4.2.2. Stainless Steel

9.5.4.2.3. Others

9.5.4.3.    Germany Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

9.5.4.3.1. Coronary Artery Diseases

9.5.4.3.2. Peripheral Artery Diseases

9.5.5.   Italy

9.5.5.1.    Italy Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

9.5.5.1.1.    Polymer-Based Coatings

9.5.5.1.1.1.  Non-Biodegradable Polymer-Based

9.5.5.1.1.2.  Biodegradable Polymer-Based

9.5.5.1.2.    Polymer-Free Coatings

9.5.5.1.2.1.  Micro Porous Surface

9.5.5.1.2.2.  Micro Structured Surface

9.5.5.1.2.3.  Slotted Tubular Surface

9.5.5.1.2.4.  Nanoporous Surface

9.5.5.2.    Italy Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

9.5.5.2.1.   Cobalt Chromium (CoCr)

9.5.5.2.2.   Stainless Steel

9.5.5.2.3.   Others

9.5.5.3.    Italy Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

9.5.5.3.1.   Coronary Artery Diseases

9.5.5.3.2.   Peripheral Artery Diseases

9.5.6.   Rest of Europe

9.5.6.1.    Rest of Europe Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

9.5.6.1.1.    Polymer-Based Coatings

9.5.6.1.1.1.  Non-Biodegradable Polymer-Based

9.5.6.1.1.2.  Biodegradable Polymer-Based

9.5.6.1.2.    Polymer-Free Coatings

9.5.6.1.2.1.  Micro Porous Surface

9.5.6.1.2.2.  Micro Structured Surface

9.5.6.1.2.3.  Slotted Tubular Surface

9.5.6.1.2.4.  Nanoporous Surface

9.5.6.2.    Rest of Europe Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

9.5.6.2.1.   Cobalt Chromium (CoCr)

9.5.6.2.2.   Stainless Steel

9.5.6.2.3.   Others

9.5.6.3.    Rest of Europe Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

9.5.6.3.1.   Coronary Artery Diseases

9.5.6.3.2.   Peripheral Artery Diseases

9.6.   Key Segment for Channeling Investments

9.6.1. By Country

9.6.2. By Product Type

9.6.3. By Material Type

9.6.4. By Application

10. Asia Pacific  Drug Eluting Stents Market Analysis and Forecasts, 2018 – 2026

10.1. Overview

10.1.1. Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn)

10.2. Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

10.2.1. Polymer-Based Coatings

10.2.1.1.  Non-Biodegradable Polymer-Based

10.2.1.2.  Biodegradable Polymer-Based

10.2.2. Polymer-Free Coatings

10.2.2.1.  Micro Porous Surface

10.2.2.2.  Micro Structured Surface

10.2.2.3.  Slotted Tubular Surface

10.2.2.4.  Nanoporous Surface

10.3. Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

10.3.1. Cobalt Chromium (CoCr)

10.3.2. Stainless Steel

10.3.3. Others

10.4. Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

10.4.1. Coronary Artery Diseases

10.4.2. Peripheral Artery Diseases

10.5. Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Country

10.5.1. China

10.5.1.1.  China Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

10.5.1.1.1.  Polymer-Based Coatings

10.5.1.1.1.1.  Non-Biodegradable Polymer-Based

10.5.1.1.1.2.  Biodegradable Polymer-Based

10.5.1.1.2.  Polymer-Free Coatings

10.5.1.1.2.1.  Micro Porous Surface

10.5.1.1.2.2.  Micro Structured Surface

10.5.1.1.2.3.  Slotted Tubular Surface

10.5.1.1.2.4.  Nanoporous Surface

10.5.1.2.  China Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

10.5.1.2.1.  Cobalt Chromium (CoCr)

10.5.1.2.2.  Stainless Steel

10.5.1.2.3.  Others

10.5.1.3.  China Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

10.5.1.3.1.  Coronary Artery Diseases

10.5.1.3.2.  Peripheral Artery Diseases

10.5.2. Japan

10.5.2.1.  Japan Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

10.5.2.1.1.  Polymer-Based Coatings

10.5.2.1.1.1.  Non-Biodegradable Polymer-Based

10.5.2.1.1.2.  Biodegradable Polymer-Based

10.5.2.1.2.  Polymer-Free Coatings

10.5.2.1.2.1.  Micro Porous Surface

10.5.2.1.2.2.  Micro Structured Surface

10.5.2.1.2.3.  Slotted Tubular Surface

10.5.2.1.2.4.  Nanoporous Surface

10.5.2.2.  Japan Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

10.5.2.2.1.  Cobalt Chromium (CoCr)

10.5.2.2.2.  Stainless Steel

10.5.2.2.3.  Others

10.5.2.3.  Japan Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

10.5.2.3.1.  Coronary Artery Diseases

10.5.2.3.2.  Peripheral Artery Diseases

10.5.3. India

10.5.3.1.  India Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

10.5.3.1.1.  Polymer-Based Coatings

10.5.3.1.1.1.  Non-Biodegradable Polymer-Based

10.5.3.1.1.2.  Biodegradable Polymer-Based

10.5.3.1.2.  Polymer-Free Coatings

10.5.3.1.2.1.  Micro Porous Surface

10.5.3.1.2.2.  Micro Structured Surface

10.5.3.1.2.3.  Slotted Tubular Surface

10.5.3.1.2.4.  Nanoporous Surface

10.5.3.2.  India Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

10.5.3.2.1.  Cobalt Chromium (CoCr)

10.5.3.2.2.  Stainless Steel

10.5.3.2.3.  Others

10.5.3.3.  India Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

10.5.3.3.1.  Coronary Artery Diseases

10.5.3.3.2.  Peripheral Artery Diseases

10.5.4. Southeast Asia

10.5.4.1.  Southeast Asia Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

10.5.4.1.1.  Polymer-Based Coatings

10.5.4.1.1.1.  Non-Biodegradable Polymer-Based

10.5.4.1.1.2.  Biodegradable Polymer-Based

10.5.4.1.2.  Polymer-Free Coatings

10.5.4.1.2.1.  Micro Porous Surface

10.5.4.1.2.2.  Micro Structured Surface

10.5.4.1.2.3.  Slotted Tubular Surface

10.5.4.1.2.4.  Nanoporous Surface

10.5.4.2.  Southeast Asia Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

10.5.4.2.1.  Cobalt Chromium (CoCr)

10.5.4.2.2.  Stainless Steel

10.5.4.2.3.  Others

10.5.4.3.  Southeast Asia Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

10.5.4.3.1.  Coronary Artery Diseases

10.5.4.3.2.  Peripheral Artery Diseases

10.5.5. Rest of Asia Pacific

10.5.5.1.  Rest of Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

10.5.5.1.1.  Polymer-Based Coatings

10.5.5.1.1.1.  Non-Biodegradable Polymer-Based

10.5.5.1.1.2.  Biodegradable Polymer-Based

10.5.5.1.2.  Polymer-Free Coatings

10.5.5.1.2.1.  Micro Porous Surface

10.5.5.1.2.2.  Micro Structured Surface

10.5.5.1.2.3.  Slotted Tubular Surface

10.5.5.1.2.4.  Nanoporous Surface

10.5.5.2.  Rest of Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

10.5.5.2.1.  Cobalt Chromium (CoCr)

10.5.5.2.2.  Stainless Steel

10.5.5.2.3.  Others

10.5.5.3.  Rest of Asia Pacific Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

10.5.5.3.1.  Coronary Artery Diseases

10.5.5.3.2.  Peripheral Artery Diseases

10.6. Key Segment for Channeling Investments

10.6.1. By Country

10.6.2. By Product Type

10.6.3. By Material Type

10.6.4. By Application

11. Middle East and Africa  Drug Eluting Stents Market Analysis and Forecasts, 2018 – 2026

11.1. Overview

11.1.1. Middle East and Africa Drug Eluting Stents Market Revenue (US$ Mn)

11.2. Middle East and Africa Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

11.2.1. Polymer-Based Coatings

11.2.1.1.  Non-Biodegradable Polymer-Based

11.2.1.2.  Biodegradable Polymer-Based

11.2.2. Polymer-Free Coatings

11.2.2.1.  Micro Porous Surface

11.2.2.2.  Micro Structured Surface

11.2.2.3.  Slotted Tubular Surface

11.2.2.4.  Nanoporous Surface

11.3. Middle East and Africa Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

11.3.1. Cobalt Chromium (CoCr)

11.3.2. Stainless Steel

11.3.3. Others

11.4. Middle East and Africa Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

11.4.1. Coronary Artery Diseases

11.4.2. Peripheral Artery Diseases

11.5. Middle East and Africa Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Country

11.5.1. GCC Countries

11.5.1.1.  GCC Countries Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

11.5.1.1.1.  Polymer-Based Coatings

11.5.1.1.1.1.  Non-Biodegradable Polymer-Based

11.5.1.1.1.2.  Biodegradable Polymer-Based

11.5.1.1.2.  Polymer-Free Coatings

11.5.1.1.2.1.  Micro Porous Surface

11.5.1.1.2.2.  Micro Structured Surface

11.5.1.1.2.3.  Slotted Tubular Surface

11.5.1.1.2.4.  Nanoporous Surface

11.5.1.2.  GCC Countries Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

11.5.1.2.1.  Cobalt Chromium (CoCr)

11.5.1.2.2.  Stainless Steel

11.5.1.2.3.  Others

11.5.1.3.  GCC Countries Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

11.5.1.3.1.  Coronary Artery Diseases

11.5.1.3.2.  Peripheral Artery Diseases

11.5.2. Southern Africa

11.5.2.1.  Southern Africa Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

11.5.2.1.1.  Polymer-Based Coatings

11.5.2.1.1.1.  Non-Biodegradable Polymer-Based

11.5.2.1.1.2.  Biodegradable Polymer-Based

11.5.2.1.2.  Polymer-Free Coatings

11.5.2.1.2.1.  Micro Porous Surface

11.5.2.1.2.2.  Micro Structured Surface

11.5.2.1.2.3.  Slotted Tubular Surface

11.5.2.1.2.4.  Nanoporous Surface

11.5.2.2.  Southern Africa Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

11.5.2.2.1.  Cobalt Chromium (CoCr)

11.5.2.2.2.  Stainless Steel

11.5.2.2.3.  Others

11.5.2.3.  Southern Africa Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

11.5.2.3.1.  Coronary Artery Diseases

11.5.2.3.2.  Peripheral Artery Diseases

11.5.3. Rest of MEA

11.5.3.1.  Rest of MEA Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

11.5.3.1.1.  Polymer-Based Coatings

11.5.3.1.1.1.  Non-Biodegradable Polymer-Based

11.5.3.1.1.2.  Biodegradable Polymer-Based

11.5.3.1.2.  Polymer-Free Coatings

11.5.3.1.2.1.  Micro Porous Surface

11.5.3.1.2.2.  Micro Structured Surface

11.5.3.1.2.3.  Slotted Tubular Surface

11.5.3.1.2.4.  Nanoporous Surface

11.5.3.2.  Rest of MEA Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

11.5.3.2.1.  Cobalt Chromium (CoCr)

11.5.3.2.2.  Stainless Steel

11.5.3.2.3.  Others

11.5.3.3.  Rest of MEA Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

11.5.3.3.1.  Coronary Artery Diseases

11.5.3.3.2.  Peripheral Artery Diseases

11.6. Key Segment for Channeling Investments

11.6.1. By Country

11.6.2. By Product Type

11.6.3. By Material Type

11.6.4. By Application

12. Latin America Drug Eluting Stents Market Analysis and Forecasts, 2018 – 2026

12.1. Overview

12.1.1. Latin America Drug Eluting Stents Market Revenue (US$ Mn)

12.2. Latin America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

12.2.1. Polymer-Based Coatings

12.2.1.1.  Non-Biodegradable Polymer-Based

12.2.1.2.  Biodegradable Polymer-Based

12.2.2. Polymer-Free Coatings

12.2.2.1.  Micro Porous Surface

12.2.2.2.  Micro Structured Surface

12.2.2.3.  Slotted Tubular Surface

12.2.2.4.  Nanoporous Surface

12.3. Latin America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

12.3.1. Cobalt Chromium (CoCr)

12.3.2. Stainless Steel

12.3.3. Others

12.4. Latin America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

12.4.1. Coronary Artery Diseases

12.4.2. Peripheral Artery Diseases

12.5. Latin America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Country

12.5.1. Brazil

12.5.1.1.  Brazil Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

12.5.1.1.1.  Polymer-Based Coatings

12.5.1.1.1.1.  Non-Biodegradable Polymer-Based

12.5.1.1.1.2.  Biodegradable Polymer-Based

12.5.1.1.2.  Polymer-Free Coatings

12.5.1.1.2.1.  Micro Porous Surface

12.5.1.1.2.2.  Micro Structured Surface

12.5.1.1.2.3.  Slotted Tubular Surface

12.5.1.1.2.4.  Nanoporous Surface

12.5.1.2.  Brazil Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

12.5.1.2.1.  Cobalt Chromium (CoCr)

12.5.1.2.2.  Stainless Steel

12.5.1.2.3.  Others

12.5.1.3.  Brazil Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

12.5.1.3.1.  Coronary Artery Diseases

12.5.1.3.2.  Peripheral Artery Diseases

12.5.2. Rest of Latin America

12.5.2.1.  Rest of Latin America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Product Type

12.5.2.1.1.  Polymer-Based Coatings

12.5.2.1.1.1.  Non-Biodegradable Polymer-Based

12.5.2.1.1.2.  Biodegradable Polymer-Based

12.5.2.1.2.  Polymer-Free Coatings

12.5.2.1.2.1.  Micro Porous Surface

12.5.2.1.2.2.  Micro Structured Surface

12.5.2.1.2.3.  Slotted Tubular Surface

12.5.2.1.2.4.  Nanoporous Surface

12.5.2.2.  Rest of Latin America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Material Type

12.5.2.2.1.  Cobalt Chromium (CoCr)

12.5.2.2.2.  Stainless Steel

12.5.2.2.3.  Others

12.5.2.3.  Rest of Latin America Drug Eluting Stents Market Revenue (US$ Mn) and Forecasts, By Application

12.5.2.3.1.  Coronary Artery Diseases

12.5.2.3.2.  Peripheral Artery Diseases

12.6. Key Segment for Channeling Investments

12.6.1. By Country

12.6.2. By Product Type

12.6.3. By Material Type

12.6.4. By Application

13. Competitive Benchmarking

13.1. Player Positioning Analysis

13.2. Global Presence and Growth Strategies

14. Player Profiles

14.1. Abbott Laboratories (Abbott)

14.1.1. Company Details

14.1.2. Company Overview

14.1.3. Product Offerings

14.1.4. Key Developments

14.1.5. Financial Analysis

14.1.6. SWOT Analysis

14.1.7. Business Strategies

14.2. Alvimedica

14.2.1. Company Details

14.2.2. Company Overview

14.2.3. Product Offerings

14.2.4. Key Developments

14.2.5. Financial Analysis

14.2.6. SWOT Analysis

14.2.7. Business Strategies

14.3. Arterius Limited (Arterius)

14.3.1. Company Details

14.3.2. Company Overview

14.3.3. Product Offerings

14.3.4. Key Developments

14.3.5. Financial Analysis

14.3.6. SWOT Analysis

14.3.7. Business Strategies

14.4. B. Braun Melsungen AG

14.4.1. Company Details

14.4.2. Company Overview

14.4.3. Product Offerings

14.4.4. Key Developments

14.4.5. Financial Analysis

14.4.6. SWOT Analysis

14.4.7. Business Strategies

14.5. Biosensors International Group, Ltd.

14.5.1. Company Details

14.5.2. Company Overview

14.5.3. Product Offerings

14.5.4. Key Developments

14.5.5. Financial Analysis

14.5.6. SWOT Analysis

14.5.7. Business Strategies

14.6. Biotronik SE  Co. KG

14.6.1. Company Details

14.6.2. Company Overview

14.6.3. Product Offerings

14.6.4. Key Developments

14.6.5. Financial Analysis

14.6.6. SWOT Analysis

14.6.7. Business Strategies

14.7. Boston Scientific Corporation

14.7.1. Company Details

14.7.2. Company Overview

14.7.3. Product Offerings

14.7.4. Key Developments

14.7.5. Financial Analysis

14.7.6. SWOT Analysis

14.7.7. Business Strategies

14.8. Cook Medical Inc.(Cook)

14.8.1. Company Details

14.8.2. Company Overview

14.8.3. Product Offerings

14.8.4. Key Developments

14.8.5. Financial Analysis

14.8.6. SWOT Analysis

14.8.7. Business Strategies

14.9. Elixir Medical Corporation

14.9.1. Company Details

14.9.2. Company Overview

14.9.3. Product Offerings

14.9.4. Key Developments

14.9.5. Financial Analysis

14.9.6. SWOT Analysis

14.9.7. Business Strategies

14.10. KYOTO MEDICAL PLANNING Co., Ltd.

14.10.1.  Company Details

14.10.2.  Company Overview

14.10.3.  Product Offerings

14.10.4.  Key Developments

14.10.5.  Financial Analysis

14.10.6.  SWOT Analysis

14.10.7.  Business Strategies

14.11. Micell Technologies, Inc. 

14.11.1.  Company Details

14.11.2.  Company Overview

14.11.3.  Product Offerings

14.11.4.  Key Developments

14.11.5.  Financial Analysis

14.11.6.  SWOT Analysis

14.11.7.  Business Strategies

14.12. OrbusNeich Medical Company Limited (ORBUSNEICH)

14.12.1.  Company Details

14.12.2.  Company Overview

14.12.3.  Product Offerings

14.12.4.  Key Developments

14.12.5.  Financial Analysis

14.12.6.  SWOT Analysis

14.12.7.  Business Strategies

14.13. QualiMed

14.13.1.  Company Details

14.13.2.  Company Overview

14.13.3.  Product Offerings

14.13.4.  Key Developments

14.13.5.  Financial Analysis

14.13.6.  SWOT Analysis

14.13.7.  Business Strategies

14.14. Shanghai MicroPort Medical (MicroPort Scientific Corporation),

14.14.1.  Company Details

14.14.2.  Company Overview

14.14.3.  Product Offerings

14.14.4.  Key Developments

14.14.5.  Financial Analysis

14.14.6.  SWOT Analysis

14.14.7.  Business Strategies

14.15. TERUMO CORPORATION

14.15.1.  Company Details

14.15.2.  Company Overview

14.15.3.  Product Offerings

14.15.4.  Key Developments

14.15.5.  Financial Analysis

14.15.6.  SWOT Analysis

14.15.7.  Business Strategies

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.   

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

 

Research Methodology

Methodology

Key Inclusions

Methodology

  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 0

    Filename: pages/reportpage.php

    Line Number: 204

    Backtrace:

    File: /home/absolute/public_html/application/views/pages/reportpage.php
    Line: 204
    Function: _error_handler

    File: /home/absolute/public_html/application/controllers/Report.php
    Line: 153
    Function: view

    File: /home/absolute/public_html/index.php
    Line: 315
    Function: require_once